Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

80.30USD
9:00pm IST
Price Change (% chg)

$-0.42 (-0.52%)
Prev Close
$80.72
Open
$80.93
Day's High
$81.23
Day's Low
$79.23
Volume
49,879
Avg. Vol
257,972
52-wk High
$86.05
52-wk Low
$60.64

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or... (more)

Overall

Beta: 0.46
Market Cap (Mil.): $8,485.87
Shares Outstanding (Mil.): 105.13
Dividend: --
Yield (%): --

Financials

Search Stocks

Edwards shares up on injunction against Medtronic heart valve

- Shares of Edwards Lifesciences Corp jumped 13 percent on Monday after a U.S. court temporarily halted sales of competitor Medtronic Inc's heart valve implant that uses a less-invasive procedure to spare patients from open-heart surgery.

14 Apr 2014

REFILE-US STOCKS-Futures tick up after Citi earnings; eyes on Ukraine

NEW YORK, April 14 - U.S. stock index futures edged higher on Monday, following a large selloff last session, with earnings results from Citigroup lifting sentiment while traders kept tabs on the possible escalation of hostilities in Ukraine.

14 Apr 2014

UPDATE 2-Edwards heart valve system tops Medtronic version in small study

WASHINGTON, March 30 - The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

30 Mar 2014

Edwards heart valve system tops Medtronic version in small study

WASHINGTON - The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

30 Mar 2014

Edwards heart valve system tops Medtronic version in small study

WASHINGTON, March 30 - The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

30 Mar 2014

UPDATE 2-Edwards Lifesciences net down on costs; shares slip

Feb 3 - Medical device maker Edwards Lifesciences Corp said on Monday that fourth-quarter net earnings declined from a year ago due to restructuring charges and costs for launching its next-generation replacement heart valves.

04 Feb 2014

UPDATE 1-Edwards Lifesciences net down on costs

Feb 3 - Medical device maker Edwards Lifesciences Corp said on Monday that fourth-quarter net earnings declined from a year ago due to restructuring charges and costs for launching its next-generation replacement heart valves.

04 Feb 2014

Edwards Lifesciences posts lower 4th quarter net earnings

Feb 3 - Medical device maker Edwards Lifesciences Corp said on Monday that fourth-quarter net earnings declined from a year ago as it took charges related to the rollout of its next-generation replacement heart valves.

04 Feb 2014

UPDATE 1-US court upholds Edwards heart valve patent in Medtronic case

Jan 15 - A U.S. jury strengthened Edwards Lifesciences Corp's efforts to protect sales of the company's transcatheter heart valve implants, by ruling that a competing product from Medtronic Inc infringes its patent.

16 Jan 2014

U.S. court awards Edwards damages in Medtronic patent fight

- Medtronic Inc said a U.S. jury ruled that its heart valve implant infringed a patent held by Edward Lifesciences Corp and awarded Edwards $392.5 million in damages.

15 Jan 2014

Competitors

Earnings vs. Estimates

Search Stocks